• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,4-二氢吡啶类钙通道药物组织选择性分子基础的受体模型

Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.

作者信息

Langs D A, Strong P D, Triggle D J

机构信息

Department of Molecular Biophysics, Medical Foundation of Buffalo, Inc., NY 14203.

出版信息

J Comput Aided Mol Des. 1990 Sep;4(3):215-30. doi: 10.1007/BF00125011.

DOI:10.1007/BF00125011
PMID:2177783
Abstract

Our analysis of the solid state conformations of nifedipine [dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinecarboxylate ] and its 1,4-dihydropyridine (1,4-DHP) analogues produced a cartoon description of the important interactions between these drugs and their voltage-dependent calcium channel receptor. In the present study a molecular-level detailed model of the 1,4-DHP receptor binding site has been built from the published amino acid sequence of the alpha 1 subunit of the voltage-dependent calcium channel isolated from rabbit skeletal muscle transverse tubule membranes. The voltage-sensing component of the channel described in this work differs from other reported for the homologous sodium channel in that it incorporates a water structure and a staggered, rather than eclipsed, hydrogen bonded S4 helix conformation. The major recognition surfaces of the receptor lie in helical grooves on the S4 or voltage-sensing alpha-helix that is positioned in the center of the bundle of transmembrane helices that define each of the four calcium channel domains. Multiple binding clefts defined by Arg-X-X-Arg-P-X-X-S 'reading frames' exist on the S4 strand. The tissue selectivity of nifedipine and its analogues may arise, in part, from conservative changes in the amino acid residues at the P and S positions of the reading frame that define the ester-binding regions of receptors from different tissues. The crystal structures of two tissue-selective nifedipine analogues, nimodipine [isopropyl (2-methoxyethyl) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylate ] and nitrendipine [ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridinecarboxylate] are reported. Nimodipine was observed to have an unusual ester side chain conformation that enhances the fit to the proposed ester-sensing region of the receptor.

摘要

我们对硝苯地平[1,4-二氢-2,6-二甲基-4-(2-硝基苯基)-3,5-吡啶二甲酸二甲酯]及其1,4-二氢吡啶(1,4-DHP)类似物的固态构象分析,得出了这些药物与其电压依赖性钙通道受体之间重要相互作用的直观描述。在本研究中,已根据从兔骨骼肌横管膜分离出的电压依赖性钙通道α1亚基的已发表氨基酸序列,构建了1,4-DHP受体结合位点的分子水平详细模型。本文所述通道的电压传感组件与报道的同源钠通道不同,因为它包含一个水结构以及一个交错而非重叠的氢键连接的S4螺旋构象。受体的主要识别表面位于S4或电压传感α螺旋上的螺旋凹槽中,该螺旋位于定义四个钙通道结构域中每一个的跨膜螺旋束的中心。S4链上存在由Arg-X-X-Arg-P-X-X-S“阅读框”定义的多个结合裂隙。硝苯地平及其类似物的组织选择性可能部分源于定义不同组织受体酯结合区域的阅读框中P和S位置氨基酸残基的保守变化。报道了两种组织选择性硝苯地平类似物尼莫地平[1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸(2-甲氧基乙基)异丙酯]和尼群地平[1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸甲乙酯]的晶体结构。观察到尼莫地平具有不寻常的酯侧链构象,增强了与受体拟议酯传感区域的契合度。

相似文献

1
Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.1,4-二氢吡啶类钙通道药物组织选择性分子基础的受体模型
J Comput Aided Mol Des. 1990 Sep;4(3):215-30. doi: 10.1007/BF00125011.
2
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.
J Comput Aided Mol Des. 1991 Apr;5(2):95-106. doi: 10.1007/BF00129749.
3
Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand.具有结合钙离子和二氢吡啶配体的合成钙离子通道的结构模型。
Biophys J. 1996 Jan;70(1):22-37. doi: 10.1016/S0006-3495(96)79561-9.
4
Conformational features of calcium channel agonist and antagonist analogs of nifedipine.
Mol Pharmacol. 1985 May;27(5):544-8.
5
Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.新型钙通道激动剂二氢吡啶类似物Bay k 8644对猪冠状动脉的作用:双相机械反应以及地尔硫䓬和尼莫地平对收缩的反常增强作用
J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):377-89. doi: 10.1097/00005344-198503000-00025.
6
[Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].[用于研究钙通道的分子工具:4-芳基-1,4-二氢吡啶基团新衍生物的合成及生物活性评估]
Biokhimiia. 1988 Jul;53(7):1059-68.
7
The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.二氢吡啶类钙通道调节剂对戊四氮惊厥的影响。
Brain Res Bull. 1990 Jul;25(1):211-4. doi: 10.1016/0361-9230(90)90279-9.
8
Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
J Med Chem. 1986 Dec;29(12):2504-11. doi: 10.1021/jm00162a013.
9
Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.二氢吡啶类钙通道阻滞药对大鼠脑毒蕈碱受体和α-肾上腺素能受体的影响。
Biochem Pharmacol. 1985 Jan 15;34(2):175-80. doi: 10.1016/0006-2952(85)90121-2.
10
The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.1,4-二氢吡啶受体:钙通道的一种调节成分。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S949-55.

引用本文的文献

1
High-throughput nanoscale crystallization of dihydropyridine active pharmaceutical ingredients.二氢吡啶类原料药的高通量纳米结晶。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2024 Feb 1;80(Pt 1):4-12. doi: 10.1107/S2052520623010053. Epub 2023 Dec 21.
2
Structural biology of voltage-gated calcium channels.电压门控钙通道的结构生物学。
Channels (Austin). 2024 Dec;18(1):2290807. doi: 10.1080/19336950.2023.2290807. Epub 2023 Dec 7.
3
Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats.

本文引用的文献

1
The Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas viridis.来自绿硫菌的光合反应中心。
Science. 1989 Sep 29;245(4925):1463-73. doi: 10.1126/science.245.4925.1463.
2
The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle.尼莫地平及其光学异构体和代谢产物对离体血管平滑肌的作用。
Arzneimittelforschung. 1982;32(4):338-46.
3
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
新型二氢吡啶衍生物对苯肾上腺素所致大鼠血压升高的降压作用
Res Pharm Sci. 2016 Dec;11(6):497-504. doi: 10.4103/1735-5362.194897.
4
Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones asPotassium Channel Openers in Isolated Rat Aorta.9-芳基-1,8-吖啶二酮作为钾通道开放剂在离体大鼠主动脉中的合成及其血管舒张作用
Iran J Pharm Res. 2012 Winter;11(1):229-33.
5
Synthesis of Novel 4-[1-(4-fluorobenzyl)-5-imidazolyl] Dihydropyridines and Studying their Effects on Rat Blood Pressure.新型 4-[1-(4-氟苄基)-5-咪唑基]二氢吡啶的合成及其对大鼠血压的影响研究。
Iran J Basic Med Sci. 2011 Sep;14(5):451-7.
6
Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism.尼群地平聚合物介导抗溶剂结晶:单分散球形晶体和生长机制。
Pharm Res. 2012 Jan;29(1):158-69. doi: 10.1007/s11095-011-0522-6. Epub 2011 Jul 12.
7
Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand.具有结合钙离子和二氢吡啶配体的合成钙离子通道的结构模型。
Biophys J. 1996 Jan;70(1):22-37. doi: 10.1016/S0006-3495(96)79561-9.
8
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.
J Comput Aided Mol Des. 1991 Apr;5(2):95-106. doi: 10.1007/BF00129749.
钙通道拮抗剂的晶体结构与药理活性:2,6 - 二甲基 - 3,5 - 二羧酸甲酯基 - 4 -(未取代、2 - 甲基、4 - 甲基、3 - 硝基、4 - 硝基以及2,4 - 二硝基苯基)- 1,4 - 二氢吡啶
J Med Chem. 1982 Feb;25(2):126-31. doi: 10.1021/jm00344a007.
4
Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.尼群地平及其他钙通道阻滞剂(钙拮抗剂)治疗高血压
Fed Proc. 1983 Feb;42(2):196-200.
5
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.钙通道拮抗剂的晶体结构:2,6 - 二甲基 - 3,5 - 二羧酸甲酯基 - 4 - [2 - 硝基 -、3 - 氰基 -、4 -(二甲氨基) - 和2,3,4,5,6 - 五氟苯基] - 1,4 - 二氢吡啶
J Med Chem. 1980 Dec;23(12):1442-5. doi: 10.1021/jm00186a029.
6
"Hantzsch-type" dihydropyridine hypotensive agents. 3.
J Med Chem. 1974 Sep;17(9):956-65. doi: 10.1021/jm00255a010.
7
Existence of distinct sodium channel messenger RNAs in rat brain.大鼠脑中不同钠通道信使核糖核酸的存在。
Nature. 1986;320(6058):188-92. doi: 10.1038/320188a0.
8
Energetics of the structure of the four-alpha-helix bundle in proteins.蛋白质中四α-螺旋束结构的能量学
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4295-9. doi: 10.1073/pnas.85.12.4295.
9
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.异丁基甲基 2,6 - 二甲基 - 4 -(取代苯基)- 1,4 - 二氢吡啶 - 3,5 - 二羧酸酯(尼索地平)系列1,4 - 二氢吡啶类钙通道拮抗剂的晶体结构与药理活性
J Med Chem. 1988 Feb;31(2):300-5. doi: 10.1021/jm00397a005.
10
Primary structure of the receptor for calcium channel blockers from skeletal muscle.骨骼肌中钙通道阻滞剂受体的一级结构。
Nature. 1987;328(6128):313-8. doi: 10.1038/328313a0.